drug
as of 2026-07-01NS-136
at a glance
small molecule
Pre-approval / investigational in the US
Developed by NeuShen Therapeutics
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia
NCT07521683Phase 2Enrolling By Invitation
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication